CHINA JO-JO DRUGSTORES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or

          Standard; Transfer of Listing.

Regaining NASDAQ Continued Listing Compliance

As previously disclosed, on October 16, 2020, China Jo-Jo Drugstores, Inc. (the "Company") received a letter from The Nasdaq Stock Exchange ("NASDAQ") regarding the Company's failure to comply with NASDAQ Continued Listing Rule ("Rule") 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.

On December 17, 2020, NASDAQ notified the Company that it has determined that from November 18 to December 14, 2020, the closing bid price of the Company's common stock has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Rule 5550(a)(2).

1

© Edgar Online, source Glimpses